Tech Company Financing Transactions
Nautilus Biotechnology Funding Round
Nautilus Biotechnology, based in San Carlos, secured $76 million in investment from Vulcan Capital, AME Cloud Ventures and Andreessen Horowitz.
Transaction Overview
Company Name
Announced On
5/22/2020
Transaction Type
Venture Equity
Amount
$76,000,000
Round
Series B
Investors
Proceeds Purpose
The capital will be used to accelerate development of Nautilus' proprietary proteomics platform and the expansion of scientific and engineering staff across a variety of levels and disciplines.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
201 Industrial Rd. 310
San Carlos, CA 94070
USA
San Carlos, CA 94070
USA
Phone
Website
Email Address
Overview
Nautilus is a biotechnology company founded in 2016 and based in San Carlos, CA and Seattle, WA. At Nautilus, we firmly believe that audacious challenges can only be overcome by people and organizations that act boldly and with clear intention; thus, we are Pioneers, we are Risk Takers, and we act with Courage.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sujal Patel
Chief Scientific Officer
Parag Mallick
Browse more venture capital transactions:
Prev: 5/22/2020: C3Nano venture capital transaction
Next: 5/22/2020: All of Us venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records reported here are derived from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs